Emil D. Kakkis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Emil D. Kakkis
Emil D. Kakkis is recorded as CEO and Board Member at Ultragenyx Pharmaceutical Inc. (RARE). The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $11,405,535 for Emil D. Kakkis in fiscal 2025, including a base salary of $861,100. Disclosed compensation is on record for 9 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-14–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
- Daniel G. Welch Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $861,100 | $11,405,535 |
| 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $856,008 | $13,717,687 |
| 2023 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $823,692 | $13,077,993 |
| 2022 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $796,154 | $12,140,330 |
| 2021 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $768,846 | $9,522,738 |
| 2020 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $759,231 | $5,144,220 |
| 2019 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $714,000 | $6,553,142 |
| 2018 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $679,952 | $4,845,627 |
| 2017 | Ultragenyx Pharmaceutical Inc. (RARE) | M.D., Ph.D. President and Chief Executive Officer | $638,115 | $6,684,899 |
Recent activity
No call appearances or filed executive changes recorded yet.